BARD1 26-327 pET28a Citations (4)

Originally described in: A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination.
Brzovic PS, Lissounov A, Christensen DE, Hoyt DW, Klevit RE Mol Cell. 2006 Mar 17. 21(6):873-80. PubMed Journal

---

Articles Citing BARD1 26-327 pET28a

Articles
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs. Atipairin A, Canyuk B, Ratanaphan A. Breast Cancer Res Treat. 2011 Feb;126(1):203-9. doi: 10.1007/s10549-010-1182-7. Epub 2010 Sep 29. PubMed
Substitution of aspartic acid with glutamic acid at position 67 of the BRCA1 RING domain retains ubiquitin ligase activity and zinc(II) binding with a reduced transition temperature. Atipairin A, Canyuk B, Ratanaphan A. J Biol Inorg Chem. 2011 Feb;16(2):217-26. doi: 10.1007/s00775-010-0718-y. Epub 2010 Oct 22. PubMed
In Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein. Atipairin A, Ratanaphan A. Breast Cancer (Auckl). 2011;5:201-8. doi: 10.4137/BCBCR.S8184. Epub 2011 Sep 25. PubMed
L ARP7 Is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis. Zhang F, Yan P, Yu H, Le H, Li Z, Chen J, Liang X, Wang S, Wei W, Liu L, Zhang Y, Ji X, Xie A, Chen W, Han Z, Pu WT, Chen S, Chen Y, Sun K, Ge B, Zhang B. Cell Rep. 2020 Jul 28;32(4):107974. doi: 10.1016/j.celrep.2020.107974. PubMed

If you have published an article using this material, please email us at to have your article added to this page.